BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 25668477)

  • 1. Targeting respiratory complex I to prevent the Warburg effect.
    Vatrinet R; Iommarini L; Kurelac I; De Luise M; Gasparre G; Porcelli AM
    Int J Biochem Cell Biol; 2015 Jun; 63():41-5. PubMed ID: 25668477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for mitochondria-targeting strategies in cancer bioenergetic therapies.
    Jose C; Rossignol R
    Int J Biochem Cell Biol; 2013 Jan; 45(1):123-9. PubMed ID: 22776740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding Warburg's hypothesis: tumor-related mutations in the mitochondrial respiratory chain.
    Garcia-Heredia JM; Carnero A
    Oncotarget; 2015 Dec; 6(39):41582-99. PubMed ID: 26462158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in Cancer Metabolism: New Concepts in an Old Field.
    Gentric G; Mieulet V; Mechta-Grigoriou F
    Antioxid Redox Signal; 2017 Mar; 26(9):462-485. PubMed ID: 27228792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor WWOX moderates the mitochondrial respiratory complex.
    Choo A; O'Keefe LV; Lee CS; Gregory SL; Shaukat Z; Colella A; Lee K; Denton D; Richards RI
    Genes Chromosomes Cancer; 2015 Dec; 54(12):745-61. PubMed ID: 26390919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells.
    Li X; Han G; Li X; Kan Q; Fan Z; Li Y; Ji Y; Zhao J; Zhang M; Grigalavicius M; Berge V; Goscinski MA; Nesland JM; Suo Z
    Oncotarget; 2017 Jul; 8(28):46363-46380. PubMed ID: 28624784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
    El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
    Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drivers of the Warburg phenotype.
    Cairns RA
    Cancer J; 2015; 21(2):56-61. PubMed ID: 25815844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of microRNAs in the Warburg effect and mitochondrial metabolism in cancer.
    Jin LH; Wei C
    Asian Pac J Cancer Prev; 2014; 15(17):7015-9. PubMed ID: 25227784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
    Pathania D; Millard M; Neamati N
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria and cancer: Warburg addressed.
    Wallace DC
    Cold Spring Harb Symp Quant Biol; 2005; 70():363-74. PubMed ID: 16869773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Warburg effect and its cancer therapeutic implications.
    Chen Z; Lu W; Garcia-Prieto C; Huang P
    J Bioenerg Biomembr; 2007 Jun; 39(3):267-74. PubMed ID: 17551814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction to the molecular basis of cancer metabolism and the Warburg effect.
    Ngo DC; Ververis K; Tortorella SM; Karagiannis TC
    Mol Biol Rep; 2015 Apr; 42(4):819-23. PubMed ID: 25672512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on therapeutic opportunities offered by cancer glycolytic metabolism.
    Granchi C; Fancelli D; Minutolo F
    Bioorg Med Chem Lett; 2014 Nov; 24(21):4915-25. PubMed ID: 25288186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria and Cancer.
    Zong WX; Rabinowitz JD; White E
    Mol Cell; 2016 Mar; 61(5):667-676. PubMed ID: 26942671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Mitochondrial Metabolic Network: A Promising Strategy in Cancer Treatment.
    Frattaruolo L; Brindisi M; Curcio R; Marra F; Dolce V; Cappello AR
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.